Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Peloton Interactive Inc (PTON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs Peloton Interactive Inc — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.10B), while Peloton Interactive Inc trades at $5.04 (market cap $2.30B). The key difference: Ionis Pharmaceuticals Inc. Common Stock is far larger — about 3.1× Peloton Interactive Inc's market cap, and Peloton Interactive Inc is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Peloton Interactive Inc for 37 Days on average.
| IONS | PTON | |
|---|---|---|
Market Cap | $7.10B | $2.30B |
Volume | 2,027,457 | 9,511,173 |
Sector | Health | Consumer Cyclical |
52-Week High | $86.50 | $7.86 |
52-Week Low | $42.38 | $3.71 |
Typical Hold Time | 0 Days | 37 Days |
Enterprise Value | $6.66B | $2.80B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Peloton (PTON) trades at $5.22, up 1.56% in the last session, with a bullish technical signal and neutral oscillators. The company reported its first profitable year in 2026 with a net income margin of 2.58%, though recent quarterly earnings have been mixed. Revenue has declined from $3.6B in 2022 to $2.4B in 2026, but cost-cutting and new product launches, like the foldable Tread Flex, aim to revive growth. Cash flow from operations turned positive in 2025 at $333M, and debt-to-asset ratio improved to 63.18% in 2026 from 70.53% in 2025.
The outlook is cautiously optimistic with a consensus price target of $8.00, implying 53% upside, but risks include subscriber declines, high debt, and intense competition. Analyst sentiment is split with 50% buy ratings, yet insider sales and volatile earnings pose challenges for sustained shareholder value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About Peloton Interactive Inc
Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.
Read more on PTON →
